תאריך רישום: March 22, 2021

מסלול הגשה: תכשיר גנרי

יצרן: CTS CHEMICAL INDUSTRIES LTD, ISRAEL

בעל רישום: CTS CHEMICAL INDUSTRIES LTD, ISRAEL

M01AC05 :ATC Code

תאריך רישום: July 27, 2022

מסלול הגשה: תכשיר גנרי

יצרן: AS GRINDEKS, LATVIA

בעל רישום: A.L. MEDI-MARKET LTD.

A02BC02 :ATC Code

תאריך רישום: December 1, 2022

מסלול הגשה: תכשיר גנרי

יצרן: PLIVA CROATIA LTD, CROATIA

בעל רישום: TEVA ISRAEL LTD

:ATC Code

תאריך רישום: June 2, 2018

מסלול הגשה: ביו סימילאר

יצרן: LABORATORIOS FARMACEUTICOS ROVI, S.A.

בעל רישום: TZAMAL BIO-PHARMA LTD

B01AB05 :ATC Code

4.1 Therapeutic indications This medicinal product is indicated in adults for: • Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery. • Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism. • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE likely to require thrombolytic therapy or surgery. • Prevention of thrombus formation in extra corporeal circulation during haemodialysis. • Acute coronary syndrome: - Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid. - Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).

תאריך רישום: May 1, 2022

מסלול הגשה: תכשיר גנרי

יצרן: LABORATÓRIOS BASI - INDÚSTRIA FARMACÊUTICA, S.A., PORTUGAL

בעל רישום: RAZ PHARMACEUTICS LTD, ISRAEL

B05XA03 :ATC Code

תאריך רישום: June 2, 2024

מסלול הגשה: אחר

יצרן: BEN SHIMON FLORIS LTD, ISRAEL

בעל רישום: BEN SHIMON FLORIS LTD, ISRAEL

A12CA01 :ATC Code